We are excited to announce that UELifeSciences will host a sponsored session at the upcoming WorldCancer Congress 2024 in Geneva, Switzerland, fromSeptember 17-19, 2024. The event will provide a platform for global
stakeholders to address disparities in cancer care, with a focus on
prevention, screening, and early detection innovations.

The World Cancer Congress, organized bythe Union for International Cancer Control (UICC), brings together
thought leaders, healthcare professionals, advocates, and innovators
to discuss strategies and solutions for improving global cancer
outcomes. This year's event will highlight the inequalities faced by
women in accessing lifesaving cancer care and early detection
services.

UE LifeSciences: Navigating EarlyDetection Disparities

Our sponsored session, titled"Navigating Early Detection Disparities: A Hope for Women
Everywhere", will be held on Wednesday, September 18, 2024,from 12:50 PM to 1:50 PM (Europe/Zurich) in Room 8 (Level O).This session will explore the challenges in providing accessible,
inclusive, and affordable early detection methods for women
worldwide, particularly in low and middle-income countries (LMICs).
UE LifeSciences will also be featured in UICC's "Rewriting
Cancer" film series, which will be unveiled at the World Cancer
Congress.

The film and panel will highlightstories of hope, innovation, and resilience, showcasing the global
efforts to address disparities in cancer outcomes. Our panelists will
discuss pathbreaking innovations like iBreastExam and Selfi,which are helping to bridge the gap in early detection access for
women globally. These technologies offer scalable, evidence-based
solutions to overcome the challenges of providing breast cancer
screenings, especially in underserved populations.

Key Panelists and Discussions

This session will feature esteemedpanelists from various sectors of healthcare and advocacy:

Chaired by Ari Brooks, Director ofEndocrine and Oncologic Surgery, Director of the Integrated Breast
Center at Perelman School of Medicine, University of Pennsylvania.

Mihir Shah, Founder and CEO of UELifeSciences, will discuss the transformative impact of early
detection technologies in global health.

Maimah Karmo, Founder of TigerlilyFoundation (United States), will focus on addressing disparities in
women's healthcare.

Murallitharan Munisamy, ManagingDirector of National Cancer Society of Malaysia (Malaysia), will
share insights into expanding access to early detection tools in
Southeast Asia.

Arnold Baskies, Former head of AmericanCancer Society (United States), will provide a U.S. perspective on
promoting early detection and awareness.

Jyoti Patel, Nursing manager at TataMemorial Hospital (India), will share her clinical experiences and
how innovations like iBreastExam are reshaping cancer care access in
India.

Why This Session Matters

Breast cancer is the most common cancerglobally, and early detection remains the key to successful treatment
and survival. However, millions of women still face barriers in
accessing affordable and effective screening tools. This session and
the accompanying film series will shine a spotlight on how innovative
technologies like iBreastExam are making a real difference by
providing accessible solutions to underserved women, ensuring that no
one is left behind in the fight against cancer.

AboutUE LifeSciences 

UELifeSciences is a fast-growing, award-winning women’s health
innovator. It is a leader in developing equitable and accessible
early detection tools for women’s cancers. UE LifeSciences’
hallmark innovation, iBreastExam is enabling breast cancer early
detection for over 2 million women across 10 countries. The company
is soon to launch CervAIcal, a handheld mobile colposcope to screen
for cervical abnormalities. The product has already obtained CDSCO
approval in India and the European CE Mark. The company has entered
distribution partnerships with Siemens Healthineers (USA), HLL
Lifecare (India) and others. UE Lifesciences is the winner of several
global accolades including the Global Women’s HealthTech award from
The World Bank. With headquarters in the USA and subsidiaries in
India, Malaysia, Colombia and Chile, UE LifeSciences is a proud
Member of the American Cancer Society (ACS) and the Union for
International Cancer Control (UICC).

Staytuned for more updates on World Cancer Congress 2024 and our
continued efforts to make a difference in women’s healthcare.